Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients must be between the ages of 18-90 years of age.~2. Patients must be able to understand the nature of this study, give written informed consent prior to study entry, and comply with study requirements.~3. Patients must have a corneal ulcer greater than 2mm but less than 6mm in size.~4. Patients must have corneal ulcer present in only one eye.~5. Patients must agree not to wear contact lenses while on study.~Exclusion Criteria:~1. Patients with multifocal ulcers.~2. Signs of any other viral or fungal infection.~3. Treatment with antibiotics within 14 days of study entry.~4. Treatment with systemic or topical ocular antiviral agents or systemic or topical steroids or topical ocular nonsteroidal anti-inflammatory drugs (NSAIDS) during the prior 14-day period.~5. Known hypersensitivity or allergy to steroids (Loteprednol etabonate) or to any of the ingredients in the three study drugs (Besifloxacin 0.6% or Gatifloxacin 0.5% or Moxifloxacin 0.5%).~6. Contact lens only with no spectacles available.~7. Ocular surgery (including laser surgery) in either eye within 6 weeks prior to entry into this study.~8. Participation in any investigational study within the past 30 days.~9. Pregnant women, minors, or those not able to consent for themselves.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Besivance 0.6% Ophthalmic Suspension (Type: ACTIVE_COMPARATOR): A topical fluoroquinolone antimicrobial indicated for the treatment of bacterial conjunctivitis.
- Zymaxid 0.5% Ophthalmic Solution (Type: ACTIVE_COMPARATOR): A topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.
- Vigamox 0.5% Ophthalmic Solution (Type: ACTIVE_COMPARATOR): A topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.

Based on this trial design, predict the completion outcome and termination type (if applicable).